James Sondheimer
Overview
Explore the profile of James Sondheimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lidgard B, Bansal N, Zelnick L, Hoofnagle A, Chen J, Colaizzo D, et al.
J Am Soc Nephrol
. 2022 Apr;
33(7):1391-1401.
PMID: 35444055
Background: People with chronic kidney disease (CKD) are at high risk for cognitive impairment and progressive cognitive decline. Retention of protein-bound organic solutes that are normally removed by tubular secretion...
12.
Kalim S, Berg A, Karumanchi S, Thadhani R, Allegretti A, Nigwekar S, et al.
Nephrol Dial Transplant
. 2021 Mar;
37(1):139-147.
PMID: 33661286
Background: Protein carbamylation is a post-translational protein modification caused, in part, by exposure to urea's dissociation product cyanate. Carbamylation is linked to cardiovascular outcomes and mortality in dialysis-dependent end-stage kidney...
13.
Omer M, Bhat Z, Fonte N, Imran N, Sondheimer J, Osman-Malik Y
Int J Nephrol
. 2021 Feb;
2021:6661042.
PMID: 33628505
Materials And Methods: 24 patients with CUA and on RRT were evaluated at Detroit Medical Center from 2007 to 2016. Skin biopsy was used in almost all patients, along with...
14.
Grams M, Surapaneni A, Appel L, Lash J, Hsu J, Diamantidis C, et al.
Nephrol Dial Transplant
. 2020 Dec;
36(9):1685-1693.
PMID: 33326030
Background: Patients with chronic kidney disease (CKD) face risks of not only end-stage kidney disease (ESKD), cardiovascular disease (CVD) and death, but also decline in kidney function, quality of life...
15.
Saraf S, Hsu J, Ricardo A, Mehta R, Chen J, Chen T, et al.
Kidney360
. 2020 Oct;
1(7):623-630.
PMID: 33117990
Background: Chronic kidney disease (CKD) progression can be a cause and potentially a consequence of anemia. Previous studies suggesting that anemia is associated with CKD progression have not utilized methodologic...
16.
Ishigami J, Taliercio J, Feldman H, Srivastava A, Townsend R, Cohen D, et al.
J Am Soc Nephrol
. 2020 Jun;
31(8):1836-1846.
PMID: 32576601
Background: Risk of infectious disease is increased among individuals with CKD. Fibroblast growth factor 23 (FGF23) is often elevated in CKD, and may impair immune function directly or indirectly through...
17.
Zhan M, Doerfler R, Xie D, Chen J, Chen H, Diamantidis C, et al.
Am J Kidney Dis
. 2020 Apr;
76(2):184-193.
PMID: 32317121
Rationale & Objective: Safe analgesic choices are limited in chronic kidney disease (CKD). We conducted a comparative analysis of harm from opioids versus nonsteroidal anti-inflammatory drugs (NSAIDs) in CKD. Study...
18.
Ku E, Yang W, McCulloch C, Feldman H, Go A, Lash J, et al.
Am J Kidney Dis
. 2019 Nov;
75(3):394-403.
PMID: 31732235
Rationale & Objectives: Few studies have investigated racial disparities in survival among dialysis patients in a manner that considers risk factors and mortality during the phase of kidney disease before...
19.
Ishigami J, Taliercio J, Feldman H, Srivastava A, Townsend R, Cohen D, et al.
Am J Epidemiol
. 2019 Nov;
189(5):433-444.
PMID: 31673705
Persons with chronic kidney disease (CKD) are at high risk of infection. While low-grade inflammation could impair immune response, it is unknown whether inflammatory markers are associated with infection risk...
20.
Hsu C, Hsu R, Liu K, Yang J, Anderson A, Chen J, et al.
J Am Soc Nephrol
. 2019 Jun;
30(7):1271-1281.
PMID: 31235617
Background: Prior studies of adverse renal consequences of AKI have almost exclusively focused on eGFR changes. Less is known about potential effects of AKI on proteinuria, although proteinuria is perhaps...